Abstract:The deubiquitinase cylindromatosis (CYLD) functions as a tumor suppressor inhibiting cell proliferation in many cancer types including melanoma. Here we present evidence that a proportion of melanoma cells are nonetheless addicted to CYLD for survival. The expression levels of CYLD varied widely in melanoma cell lines and melanomas in vivo, with a subset of melanoma cell lines and melanomas displaying even higher levels of CYLD than melanocyte lines and nevi, respectively. Strikingly, although short hairpin RNA (shRNA) knockdown of CYLD promoted, as anticipated, cell proliferation in some melanoma cell lines, it reduced cell viability in a fraction of melanoma cell lines with relatively high levels of CYLD expression and did not impinge on survival and proliferation in a third type of melanoma cell lines. The decrease in cell viability caused by CYLD knockdown was due to induction of apoptosis, as it was associated with activation of the caspase cascade and was abolished by treatment with a general caspase inhibitor. Mechanistic investigations demonstrated that induction of apoptosis by CYLD knockdown was caused by upregulation of receptor-interacting protein kinase 1 (RIPK1) that was associated with elevated K63-linked polyubiquitination of the protein, indicating that CYLD is critical for controlling RIPK1 expression in these cells. Of note, microRNA (miR) profiling showed that miR-99b-3p that was predicted to target the 3-untranslated region (3-UTR) of the CYLD mRNA was reduced in melanoma cell lines with high levels of CYLD compared with melanocyte lines. Further functional studies confirmed that the reduction in miR-99b-3p expression was responsible for the increased expression of CYLD in a highly cell line-specific manner. Taken together, these results reveal an unexpected role of CYLD in promoting survival of a subset of melanoma cells and uncover the heterogeneity of CYLD expression and its biological significance in melanoma.

The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration

Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments

CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration.

CYLD Regulates Angiogenesis by Mediating Vascular Endothelial Cell Migration.

The Tumor Suppressor Cyld Controls Epithelial Morphogenesis and Homeostasis by Regulating Mitotic Spindle Behavior and Adherens Junction Assembly

The Microtubule Plus End Tracking Protein TIP150 Interacts with Cortactin to Steer Directional Cell Migration*

Tumour Suppressor Cyld is A Negative Regulator of the Mitotic Kinase Aurora-B

The Microtubule Plus End Tracking Protein TIP150 Interacts with Cortactin to Steer Directional Cell Migration

CYLD Mediates Ciliogenesis in Multiple Organs by Deubiquitinating Cep70 and Inactivating HDAC6.

Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.

NudCL2 Regulates Cell Migration by Stabilizing Both Myosin-9 and LIS1 with Hsp90

Tumor Suppressor Protein CYLD Regulates Morphogenesis of Dendrites and Spines

CYLD Deficiency Promotes Pancreatic Cancer Development by Causing Mitotic Defects

CYLD Regulates Spindle Orientation by Stabilizing Astral Microtubules and Promoting Dishevelled-Numa-dynein/dynactin Complex Formation

CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia Via a Microtubule-Dependent Mechanism

Cylindromatosis is Required for Survival of a Subset of Melanoma Cells.

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency

The B-box Module of CYLD is Responsible for Its Intermolecular Interaction and Cytoplasmic Localization.

CYLD Negatively Regulates Hippo Signaling by Limiting Hpo Phosphorylation in Drosophila.

Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer

CYR61 Acts as an Intracellular Microtubule-Associated Protein and Coordinates Mitotic Progression via PLK1-FBW7 Pathway